Nawei Liu

Luye Pharma (China) — China

Medicine · Health Sciences

5h-index261citations10works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(5), Chronic Lymphocytic Leukemia Research(5), CAR-T cell therapy research(3), Acute Myeloid Leukemia Research(2), Acute Lymphoblastic Leukemia research(2)

Publications10 total

Efficacy and safety of rocbrutinib, a highly selective 4th-generation BTK inhibitor, in Chinese patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Blood·2025Open Access
Efficacy and safety of rocbrutinib, a highly selective 4th-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory Mantle Cell Lymphoma (R/R MCL): Updated results from the phase 1 study
Blood·2025Open Access
Safety and Efficacy of Rocbrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma
Blood·2024· 1 citedOpen Access
Rocbrutinib, a New-Generation BTK Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Non-GCB Diffuse Large B Cell Lymphoma
Blood·2024
A Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: Safety and Efficacy Results from a Phase 1 Study
Blood·2023· 5 cited
Safety and Efficacy Results from the Phase I Study of a Novel Dual Covalent and Non-Covalent Next Generation Inhibitor of Bruton's Tyrosine Kinase LP-168 in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Blood·2023Open Access
Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients
BMC Cancer·2020· 12 citedOpen Access
Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia
Supportive Care in Cancer·2019· 27 citedOpen Access
Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
OncoTargets and Therapy·2018· 23 citedOpen Access
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
Journal of Hematology & Oncology·2018· 193 citedOpen Access

Frequent Co-authors

Yuqin Song(6), Qingqing Cai(6), Keshu Zhou(6), Xiuhua Sun(6), Zhengming Jin(6), Lanfang Li(6), Junyuan Qi(6), Wei Yang(6), Min Zhou(6), Kaiyang Ding(6), Yejiang Lou(6), Yi Chen(6), Fenlai Tan(6), Lei Zhang(5), Hongmei Jing(5), Zhigang Peng(5), Ming Jiang(5), Weida Wang(4), Wenjian Liu(4), Haiyan Yang(4)